Señales en vivo de ALTHX.PA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 11:08):

Stats
Volumen de hoy	14 521.00
Volumen promedio	37 717.00
Capitalización de mercado	8.74M
EPS	€0 ( 2024-04-11 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-0.980
ATR14	€0.0180 (1.59%)

Theranexus SA Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Theranexus SA Finanzas

Annual	2022
Ingresos:	€414 898
Beneficio Bruto:	€82 898.00 (19.98 %)
EPS:	€-1.240

FY	2022
Ingresos:	€414 898
Beneficio Bruto:	€82 898.00 (19.98 %)
EPS:	€-1.240

FY	2021
Ingresos:	€0.00
Beneficio Bruto:	€-5.55M (0.00 %)
EPS:	€-1.622

FY	2020
Ingresos:	€0.00
Beneficio Bruto:	€-3.57M (0.00 %)
EPS:	€-1.183

Financial Reports:

No articles found.

Theranexus SA

Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.

Actualizaciones en tiempo real para Theranexus SA [ALTHX.PA]

Upcoming Earnings Alert